Down-regulation of CASK in glucotoxicity-induced insulin dysfunction in pancreatic β cells

Area of Science:

• Endocrinology
• Cell Biology
• Molecular Biology

Background:

• High glucose levels are toxic to pancreatic beta cells, leading to dysfunction.
• Calcium/calmodulin-dependent serine protein kinase (CASK) is implicated in neural development and may anchor insulin in beta cells.
• Hypoxia-inducible factor 1α (HIF1α) is known to contribute to beta-cell dysfunction.

Purpose of the Study:

• To investigate the potential role of CASK in high glucose-induced (glucotoxicity) insulin secretion dysfunction.
• To explore the involvement of HIF1α in mediating the effects of glucotoxicity on CASK and insulin secretion in INS-1E cells.

Main Methods:

• Utilized CASK overexpression plasmids in INS-1E cells.
• Employed a HIF1α agonist (CoCl2) to induce effects.
• Used a HIF1α selective inhibitor (KC7F2) to block HIF1α activity.
• Assessed insulin secretion and CASK expression levels under various conditions.

Main Results:

• Chronic exposure to high glucose impaired insulin secretion in INS-1E cells.
• Overexpression of CASK partially restored insulin secretion affected by high glucose.
• CoCl2 treatment decreased CASK expression, while KC7F2 reversed this reduction caused by glucotoxicity.

Conclusions:

• Glucotoxicity-induced insulin secretion defects in INS-1E cells appear to be mediated by HIF1α.
• HIF1α exerts its effect, at least in part, through the down-regulation of CASK expression.